The HPA Axis and Mast Cells

“Stress makes symptoms worse” is true but inadequate. The actual mechanism is specific, biochemical, and measurable. Stress hormones are literal mast cell triggers — not through some vague mind-body connection, but through identified receptors and signaling pathways.

The HPA Axis

The Hypothalamic-Pituitary-Adrenal (HPA) axis is the body’s central stress response system:

1. Hypothalamus detects threat or stress → releases CRH (Corticotropin-Releasing Hormone)
2. CRH stimulates the anterior pituitary → releases ACTH (Adrenocorticotropic Hormone)
3. ACTH stimulates the adrenal cortex → releases Cortisol (glucocorticoid stress hormone)
4. Cortisol feeds back to hypothalamus and pituitary to shut off the response (negative feedback loop)

In parallel, the sympathetic nervous system activates directly, releasing adrenaline (epinephrine) and norepinephrine from the adrenal medulla and sympathetic nerve terminals.

CRH: The Direct Mast Cell Activator

This is the key molecule. CRH doesn’t just initiate the stress cascade — it directly activates mast cells.

Mast cells express CRH Receptors (CRHR-1 and CRHR-2) on their surface. When CRH binds these receptors, it triggers:

• Degranulation — release of pre-formed mediators including Histamine, Tryptase
• Selective release of Cytokines (particularly IL-6 and TNF-α) even without full degranulation
• Increased vascular permeability independently of histamine
• Release of VEGF (vascular endothelial growth factor), promoting inflammation

This is not mediated through cortisol. CRH acts on mast cells directly, before the rest of the HPA cascade completes. The stress signal reaches mast cells in seconds.

Sympathetic Nerve-Mast Cell Interaction

Mast cells are physically innervated by sympathetic nerve fibers. They sit in direct contact with nerve terminals in tissues throughout the body. This is a functional synapse — the nerve releases neurotransmitters that the mast cell responds to.

Norepinephrine can have both activating and inhibiting effects on mast cells depending on which adrenergic receptor subtype is engaged. In the context of chronic sympathetic overactivation (as in POTS or chronic stress states), the net effect tends toward mast cell activation.

Substance P, released from sensory nerve endings during stress and pain, is a potent mast cell activator. It creates a nerve-mast cell-nerve loop: pain → substance P release → mast cell activation → mediator release → nerve sensitization → more pain.

PTSD and Chronic HPA Dysregulation

In PTSD, the HPA axis doesn’t just overreact to threats — it’s recalibrated. The system is chronically dysregulated:

• Baseline CRH is elevated. The hypothalamus is producing more CRH even without an acute stressor. This means mast cells are being chronically activated by CRH at rest.
• Cortisol feedback is impaired. The negative feedback loop that should shut off the stress response is blunted. The system doesn’t return to baseline normally after activation.
• The startle response is amplified. Minor stimuli produce disproportionate sympathetic activation → adrenaline surges → mast cell activation.

The result: a person with PTSD has a higher baseline of mast cell activation and lower threshold for additional activation. The mast cells are primed by the trauma-dysregulated stress system before any external trigger is added. This is a measurable, biochemical state — not a psychological weakness.

Why this matters for self-understanding

When a person with PTSD experiences racing heart, flushing, GI distress, and a sense of doom, the question “is this anxiety or is this mast cell activation?” may have the answer “yes.” The HPA dysregulation from trauma is directly activating mast cells, which are producing mediators that create the physical sensations typically attributed to anxiety. The emotional experience and the mast cell activation can be the same event, triggered by the same upstream molecule (CRH).

This reframes “anxiety symptoms” — they’re not imagined, not exaggerated, not purely psychological. They have a measurable biochemical substrate. And they may respond to mast cell-targeted interventions in addition to (or instead of) traditional anxiolytics.

The Sensitization Spiral

Both mast cell biology and trauma neuroscience feature sensitization — repeated activation lowers the threshold for future activation:

Mast cell sensitization: Repeated degranulation can increase the density of surface receptors, increase stored mediator content, and lower the threshold for future activation. A mast cell that has been activated repeatedly becomes easier to activate next time.

Neural sensitization: In PTSD, repeated trauma responses strengthen the neural circuits that detect and respond to threats. The amygdala becomes hyperresponsive. The threshold for startle drops.

These systems reinforce each other. Trauma → HPA activation → mast cell activation → mediator release → neural sensitization → lower threshold for future stress response → more CRH → more mast cell activation.

Breaking this spiral typically requires intervention at multiple points: trauma-focused therapy (to recalibrate the HPA axis), mast cell stabilization (to reduce the mediator load), and nervous system regulation (to reduce sympathetic tone). None of these alone is usually sufficient because the spiral has multiple self-reinforcing loops.

Practical Implications

• Stress reduction isn’t a lifestyle luxury — it’s a direct intervention in Total Mediator Load
• Somatic symptoms during stress are not psychosomatic in the dismissive sense. They are mast cell-mediated, measurable, and treatable
• PTSD treatment and MCAS treatment may need to proceed in parallel
• Nervous system regulation practices (vagal toning, etc.) may help by shifting autonomic balance away from sympathetic dominance, reducing baseline mast cell activation